A Crucial Group of Covid Drugs Has Stopped Working

from What's New · host WIRED

Monoclonal antibodies were a key tool in the early pandemic response, but are now ineffective against new variants — putting immunocompromised patients at risk. Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Feb 9, 2023

Embed this episode

Attribution link and audio player

Ready to play

A Crucial Group of Covid Drugs Has Stopped Working

0:00 13:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world.

Frequently Asked Questions

How long is this episode of What's New?

This episode is 13 minutes long.

When was this What's New episode published?

This episode was published on February 9, 2023.

Can I download this What's New episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!